Research Hub for Muscle Degeneration and Rare Diseases
Muscle degeneration diseases and rare genetic diseases include some of the most severe diseases of infants and adults, the majority of which lack any effective treatment to date. Thus, finding new treatments and cures is a major goal of the medical and scientific community. One of the main obstacles for developing new treatments is the lack of communication and collaboration between different researchers and clinicians in the field that work together to better understand these diseases in order to find effective treatment protocols. The new muscle degeneration and rare diseases research hub of the Institute for Medical Research Israel-Canada (IMRIC), will overcome these obstacles. The hub enables researchers and clinicians from different fields and disciplines which study aspects of muscle degeneration diseases to get together in scientific meetings and seminars, leading also to collaborative research projects that will emanate from the hub. The IMRIC research hub gathers researchers and clinicians that are working to understand and treat different aspects of diseases such as ALS, Duchenne muscular dystrophy, Myotonic Dystrophy, Epilepsy and others, leading to muscle degeneration. This new research hub also serves as a platform for support of novel research projects of the scientists in the hub. This research hub for muscle degenerative diseases constitutes a unique interdisciplinary research framework; and the interactions, new ideas and research directions brought to the table by its diverse members are generating fruitful discussions and research collaborations within the hub that have the potential to generate groundbreaking advances in the field.
Current hub members
Rotem Karni – Duchenne Muscular Dystrophy, genetic diseases with nonsense mutations.
Yuval Tabach – Myotonic Dystrophy (DM1, DM2), ALS.
Josh Goldberg – Neurology of muscle degeneration.
Ehud Cohen – Proteotoxicity in muscle degeneration.
Chaya Kalcheim – Muscle development.
Haya Lorberboum-Galski – ALS.
Yossi Buganim – Duchenne Muscular Dystrophy.
Maayan Salton – ALS.
Rami Aqeilan – Epilepsy.
Talya Dor – Duchenne Muscular Dystrophy.
Marc Gotkine – ALS.
Dimitrios Karussis – ALS.
Stella Mitrany- Rosenbaum – Hereditary inclusion body myopathy (HIBM), Myotonic Dystrophy (DM1, DM2).
Jacob Fellig – Muscle pathology.
Rachel Eiges – Myotonic Dystrophy (DM1, DM2), ALS.
